- Published: Saturday, 14 June 2014 13:16
NorthShore Bio is featured at the Angel Capital Association (ACA) Northwest Regional Meeting in Portland, OR.
FRIDAY HARBOR, WA - (Marketwired - Dec 20, 2013) - Strategic News Service (SNS) is proud to announce that NorthShore Bio has been selected as a 2014 FiReStarter company, to be featured at the 12th annual SNS Future in Review (FiRe) conference. Described by The Economist as "the best technology conference in the world," FiRe features global thought leaders in technology and the global economy, including Elon Musk, Paul Jacobs, Mark Hurd, Vint Cerf, Leroy Hood, Azim Premji, Craig Venter, Michael Dell, and many others. FiReStarters are selected based on the strength of their innovations and their potential to bring positive change to the world, and are showcased at an exclusive investor reception at the FiRe conference, in panels throughout the event, and with ongoing relationships introduced and supported by SNS.
NorthShore Bio (NSB) is a life sciences tools and services company that focuses on the development of direct-to-digital™ nanopore chips, instrumentation appliances, and low-cost sequencing services that enable a range of tests, from simple to data-rich, making sequencing faster, simpler, and more accessible to researchers, clinicians, and field practitioners.
Read about us on GenomeWeb:
NorthShore Bio has been selected a TiE50 Top Startup Winner out of more than 1,100 companies world-wide.
TiE50 is TiE Silicon Valley's premier annual awards program keenly contested by thousands of technology startups worldwide. Awards are announced at TiEcon, the world's largest conference for entrepreneurs. TiE is a global, not-for-profit network of entrepreneurs and professionals dedicated to the advancement of entrepreneurship. TiE provides a platform for mentoring, networking and education for technology entrepreneurs worldwide.
NorthShore Bio has been selected a TiE50 finalist out of more than 1,100 companies world-wide. TiE50 is TiE Silicon Valley's premier annual awards program contested by technology startups around the globe. This year the conference is being held May 17th -18th at the Santa Clara Convention Center.
SEATTLE, WA, May 10, 2013 – NorthShore Bio (NSB), developers of digital-biology technologies, announced today that it has been able produce a silicon chip molecular detection platform composed of solid-state "tunable" nanopores that can make direct sequencing faster, simpler and more accessible to researchers, clinicians and field practitioners. The chip's proprietary silicon nanopores can be tuned, or sized, electronically to dimensions that will allow for selective identification of DNA, RNA, small molecules and ion flow.
"NSB's platform is capable of label-free direct electrical detection, making this an extremely integrated and cost-effective solution," said Jonathan DeHart, NSB co-founder and CEO. "Our goal was to create an accurate platform that is truly 'sample-in, answer-out.'"